More on GALT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.71 |
|
|||
| Open | $3.71 | ||||
| 52 Wk High | $3.05 | ||||
| 52 Wk Low | $0.49 | ||||
| Day High | $3.77 | ||||
| Day Low | $3.68 | ||||
| P/E | N/A | ||||
| EPS | $-1.32 | ||||
| Volume | 37,588 | ||||
- Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
- Form 8-K GALECTIN THERAPEUTICS For: Aug 14
- Form 10-Q GALECTIN THERAPEUTICS For: Jun 30
- Form SCHEDULE 13D/A GALECTIN THERAPEUTICS Filed by: Uihlein Richard E
- Galectin Therapeutics converts $105.8M in debt to equity
- Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
- Form 4 GALECTIN THERAPEUTICS For: Jul 31 Filed by: Uihlein Richard E
- Form 8-K GALECTIN THERAPEUTICS For: Jul 31
- Form 4 GALECTIN THERAPEUTICS For: Jul 14 Filed by: Jamil Khurram
Entities mentioned with GALT
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- S3 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
